Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

The "Cell Therapy Human Raw Materials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has ...

Ahead of his talk at the 7th Annual Allogeneic Cell Therapies Summit, Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and large-scale ...

Takeda discontinues cell therapy efforts, seeking external partnerships to leverage platform technologies and advance research programs. Focus shifts to near-term investments in small molecules, ...